15/02/2019 22:26:03

Mondelēz International to Transfer Listing of Debt Securities to Nasdaq

DEERFIELD, Ill., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) today announced its intention to transfer the securities exchange listing for its notes listed below from the New York Stock Exchange to the Nasdaq Bond Exchange effective February 25, 2019 after market close. The debt securities are expected to begin trading on the Nasdaq Bond Exchange on February 26, 2019. Their respective trading symbols and CUSIP numbers are listed below:

 

Series of debt security notes

Trading Symbol

CUSIP

 
 2.375% Notes due 2021MDLZ21EJ9735972 
 1.000% Notes due 2022MDLZ22609207AD7 
 1.625% Notes due 2023MDLZ23609207AJ4 
 1.625% Notes due 2027MDLZ27609207AE5 
 2.375% Notes due 2035MDLZ35609207AF2 
 4.500% Notes due 2035MDLZ35AQJ8168784 
 3.875% Notes due 2045MDLZ45609207AG0 

Mondelēz International is transferring the listing of the debt securities to Nasdaq to consolidate its equity and debt listings relationships under one exchange.

About Mondelēz International

Mondelēz International, Inc. (NASDAQ: MDLZ) empowers people to snack right in approximately 150 countries around the world. With 2018 net revenues of approximately $26 billion, MDLZ is leading the future of snacking with iconic global and local brands such as Oreo, belVita and LU biscuits; Cadbury Dairy Milk, Milka and Toblerone chocolate; Sour Patch Kids candy and Trident gum. Mondelēz International is a proud member of the Standard and Poor’s 500, Nasdaq 100 and Dow Jones Sustainability Index. Visit www.mondelezinternational.com or follow the company on Twitter at www.twitter.com/MDLZ.

Contacts:

Tom Armitage (Media)Shep Dunlap (Investors)

 

+1-847-943-5678+1-847-943-5454

 

news@mdlz.com

ir@mdlz.com

Mondelez Logo.jpg

Related content
13 Jun - 
Mondelēz International Invests $6 Million in Reading, U..
06 Jun - 
Mondelēz International to Present at Deutsche Bank Glob..
30 May - 
Mondelēz International Completes Sale of Cheese Busines..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
2
REV DEADLINE: Rosen, a Highly Ranked Law Firm, Reminds Revlon, Inc. Investors of Important July 15th Deadline in Securities Class Action – REV
3
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
4
FSIS Recall 069-2019 Foreign Matter Contamination: RUIZ FOODS PRODUCTS INC. RECALLS BACON BREAKFAST WRAP PRODUCTS DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION
5
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 04:29:58
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB3 - 2019-06-16 05:29:58 - 2019-06-16 04:29:58 - 1000 - Website: OKAY